Your browser doesn't support javascript.
loading
Technologies for intrapericardial delivery of therapeutics and cells.
Filgueira, Carly S; Igo, Stephen R; Wang, Dennis K; Hirsch, Matteo; Schulz, Daryl G; Bruckner, Brian A; Grattoni, Alessandro.
Afiliação
  • Filgueira CS; Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX 77030, USA. Electronic address: csfilgueira@houstonmethodist.org.
  • Igo SR; Methodist DeBakey Heart & Vascular Center, Houston Methodist Hospital, Houston, TX 77030, USA.
  • Wang DK; Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX 77030, USA.
  • Hirsch M; Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX 77030, USA.
  • Schulz DG; Pre-clinical Catheterization Core Lab, Houston Methodist Research Institute, Houston, TX 77030, USA.
  • Bruckner BA; Methodist DeBakey Heart & Vascular Center, Houston Methodist Hospital, Houston, TX 77030, USA.
  • Grattoni A; Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX 77030, USA. Electronic address: agrattoni@houstonmethodist.org.
Adv Drug Deliv Rev ; 151-152: 222-232, 2019.
Article em En | MEDLINE | ID: mdl-30797957
ABSTRACT
The pericardium, which surrounds the heart, provides a unique enclosed volume and a site for the delivery of agents to the heart and coronary arteries. While strategies for targeting the delivery of therapeutics to the heart are lacking, various technologies and nanodelivery approaches are emerging as promising methods for site specific delivery to increase therapeutic myocardial retention, efficacy, and bioactivity, while decreasing undesired systemic effects. Here, we provide a literature review of various approaches for intrapericardial delivery of agents. Emphasis is given to sustained delivery approaches (pumps and catheters) and localized release (patches, drug eluting stents, and support devices and meshes). Further, minimally invasive access techniques, pericardial access devices, pericardial washout and fluid analysis, as well as therapeutic and cell delivery vehicles are presented. Finally, several promising new therapeutic targets to treat heart diseases are highlighted.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cardiotônicos / Sistemas de Liberação de Medicamentos / Cardiopatias Limite: Animals / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cardiotônicos / Sistemas de Liberação de Medicamentos / Cardiopatias Limite: Animals / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article